Moving upstream in anticancer drug development

Nat Rev Drug Discov. 2019 Mar;18(3):159-160. doi: 10.1038/d41573-018-00006-3.
No abstract available

Publication types

  • News

MeSH terms

  • Androgen Antagonists / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Drug Approval / legislation & jurisprudence*
  • Drug Development*
  • Humans
  • Male
  • Prognosis
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / mortality
  • Prostatic Neoplasms / secondary
  • Survival Rate

Substances

  • Androgen Antagonists
  • Antineoplastic Agents